Prostaglandin biosynthesis inhibitors and endometriosis
article
OA: closed
CC0
⤵ 43 in-corpus citations
AI-generated summary
This paper investigates the role of prostaglandin biosynthesis inhibitors in endometriosis, exploring their mechanisms and potential therapeutic applications.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Prostaglandins (PGs) may be involved in the development of the symptoms of endometriosis. Therefore 18 patients with pelvic endometriosis were treated in placebo controlled double-blind trial with different prostaglandin biosynthesis inhibitors. These drugs were: acetylsalicylic acid (0.5 g x 3) exerting a weak PG-synthetase inhibition, indomethacin (25 mg x 3) inhibiting PG-synthetase, and as a representative of fenamates, tolfenamic acid (200 mg x 3), which both inhibits PG-synthetase and antagonizes PGs at the target level. The therapeutic effect was evaluated using a specific endometriosis score separately during menstruation and in premenstrum. Prostaglandin biosynthesis inhibitors did not alleviate premenstrual complaints better than placebo. During menstruation tolfenamic acid relieved endometriotic symptoms more effectively than placebo while indomethacin and acetylsalicylic acid did not differ from placebo. A drug which inhibit both the synthesis and action of PGs can thus be used in the alleviation of secondary dysmenorrhea due to endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- DYDROGESTERONE AND ENDOMETRIOSIS via openalex
- Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Mefenamic Acid in Dysmenorrhea via openalex
- New concepts in dysmenorrhea via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- W2037691565 via openalex
- W2042520066 via openalex
- W2044636737 via openalex
- W2083717098 via openalex
- W2087172187 via openalex
- W2116225234 via openalex
- W2416440242 via openalex
- W6642904790 via openalex
- W6652596821 via openalex
- W1972157578 via openalex
- W1996508035 via openalex
- W2008574207 via openalex
- W2016361834 via openalex
Cited by (43)
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Targeting inflammation in endometriosis: emerging therapeutic options 2025
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Pain Management for Women with Endometriosis 2024
- Exercise and endometriosis-is there a promising future? A narrative review 2024
- Vanillin prevents the growth of endometriotic lesions through anti-inflammatory and antioxidant pathways in a mouse model 2023
- Endometriosis-Related Chronic Pelvic Pain 2023
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Endometriosis Pain Management: a Review 2020
- Current and emerging treatment options for endometriosis 2018
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis 2017
- Pain related genes in endometriosis: A meta-analysis 2015
- Molecular aspects of development and regulation of endometriosis 2014
- New trends for the medical treatment of endometriosis 2012
- Endometriosis 2012
- Role of prostaglandin E2 in the experimental L-carnitine-induced endometriosis-like inflammatory model 2012
- Molecular profiling of human endometrium and endometriosis 2010
- An investigation of the surgical treatment of endometriosis 2010
- Medikamentöse Schmerztherapie der Endometriose 2008
- Endometriosis and pain 2007
- Endométriose et douleur 2007
- Endometriosis: A general review and rationale for surgical therapy 2006
- ESHRE guideline for the diagnosis and treatment of endometriosis 2005
- Modern Medical Therapy of Endometriosis 2004
- Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium 2004
- Aetiology and medical treatment of endometriosis 2000
- Endometriosis and Pelvic Pain 1998
- Prostaglandin Synthesis Inhibitors in Menorrhagia, Intrauterine Contraceptive Device‐Induced Side Effects and Endometriosis 1994
- A Risk Benefit Assessment of Drugs Used in the Treatment of Endometriosis 1994
- Changing concepts of medical treatment of endometriosis 1993
- Nonsteroidal antiinflammatory drugs and reproduction 1993
- 1 Is endometriosis a disease? 1993
- Treatment of endometriosis 1992
- Treatment of Menorrhagia 1992
- 8 Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders 1992
- Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine 1989
- Uterine contractions in endometriosis: Effects of operative and danazol treatment 1988
- Dysmenorrhea and Prostaglandins 1987
- Eicosanoids, menstruation and menstrual disorders 1987
- Endometriosis 1986
- Prostaglandins and Endometriosis 1983
- Peripheral nerve stimulation in the management of dysmenorrhea 1981
- The relief of primary dysmenorrhea by ketoprofen and indomethacin 1979
Source provenance
- europepmc
- last seen: 2026-08-16T09:21:09.727480+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-14T05:58:48.767648+00:00
License: CC0
· commercial use OK